Abstract
The 2009 review of human carcinogens by the International Agency for Research on Cancer (IARC) determined that there is sufficient evidence in humans to confirm the carcinogenicity of alcohol consumption. From the ample evidence provided, the positive association between alcohol intake and colorectal cancer risk is convincing. Although the site-specific mechanism by which alcohol intake influences colorectal carcinogenesis remains unknown, one notable mechanism is via an effect on the folate pathway. Genetic polymorphisms, such as aldehyde dehydrogenase 2 (ALDH2) and 5,10-methylenetetrahydrofolate reductase (MTHFR), also are suggested to influence the effect of alcohol on colorectal carcinogenesis. Although the mechanism of this carcinogenesis requires further clarification, the avoidance of excess alcohol consumption will substantially contribute to reducing the risk and burden of colorectal cancer attributable to alcohol consumption.
Similar content being viewed by others
Introduction
In its 2009 review of human carcinogens, a working group of the International Agency for Research on Cancer (IARC) concluded that there is sufficient evidence in humans to affirm the carcinogenicity of alcohol consumption. Sufficient evidence is considered available to associate alcohol consumption with various types of cancer, including cancers of the oral cavity, pharynx and larynx, esophagus, colorectum, and female breast, and hepatocellular carcinoma [1•]. In that evaluation, the authors suggested that acetaldehyde associated with alcohol consumption also causes both esophageal and upper aerodigestive tract cancers [2].
The association between alcohol consumption and colorectal cancer risk has been studied closely for a number of decades in various populations. Recent systematic reviews and meta-analyses have provided clues to quantitative evaluation of the association. In addition, increased interest in genetic studies has attracted further attention to possible gene-environment interactions on the effect of alcohol exposure on colorectal cancer.
We review epidemiological evidence obtained to date for the association between alcohol consumption and colorectal cancer risk and summarize possible mechanisms of alcohol-related carcinogenesis.
Epidemiological Evidence for Alcohol Consumption and Colorectal Cancer Risk
A substantial number of epidemiological studies have observed an increased risk of colorectal cancer with higher consumption of alcohol. The evaluation of the World Cancer Research Fund and American Institute for Cancer Research (WCRF/AICR) report in 2007 [3] reported ample, generally consistent evidence on this association, with apparent dose-response and plausible mechanisms. This report also mentioned that consumption of more than 30 g of ethanol per day from alcohol drinks is a convincing cause of colorectal cancer in men, and probably in women.
A recently detailed systematic review and meta-analysis of this association targeting 61 epidemiological studies (27 cohort studies and 34 case-control studies) in various populations provided strong evidence for the association between moderate and heavy alcohol drinking and colorectal cancer risk, in which the summary relative risk (RR) was 1.21 (95 % confidence interval (95 % CI) 1.13–1.28) for moderate drinking and 1.52 (95 % CI 1.27–1.81) for heavy drinking [4•]. In that review, epidemiological results were found generally to show consistently similar associations between anatomic subsite, namely colon and rectum, and between sexes. This review also supported the positive dose-response association by meta-analyses, with RRs of 1.07 (95 % CI 1.03–1.4), 1.38 (95 % CI 1.28–1.5), and 1.82 (95 % CI 1.41–2.35) for daily alcohol consumption of 10, 50, and 100 g, and pointed to a stronger association in heavy drinkers in Asian (RR 1.81, 95 % CI 1.33–2.46) than in western populations [4•]. Several, recent, large-scale pooled analyses have evaluated the association with greater sensitivity in settings of combined population studies. The EPIC study [5] showed that both lifelong and baseline alcohol intake elevated colon and rectal cancer risk, with risk apparently increasing with alcohol drinking more than 30 g per day and a tendency for higher risk at the distal site. The study also reported a tendency to a somewhat higher colorectal cancer risk for beer than for wine. Another pooled analysis by the Pooling Project of Prospective Studies of Diet and Cancer showed somewhat different result for type of alcohol [6], in which risk was higher for wine than beer or liquor, albeit that differences among specific beverages were not statistically meaningful.
These pooled analyses from western populations [5, 6] and another pooled analysis from Japanese populations [7] all showed a positive association, although the magnitude of relative risk was much higher in the Japanese population (pooled RR 1.42 (95 % CI 1.21–1.66), 1.95 (95 % CI 1.53–2.49), 2.15 (95 % CI 1.74–2.64), and 2.96 (95 % CI 2.27–3.86), for 23 to <46 g, 46 to <69 g, 69 to <92 g, and ≥92 g respectively, compared with nondrinkers) [7]. These higher RRs in Japanese populations might be due to their higher prevalence of the slow-metabolizing aldehyde dehydrogenase variant [8], which causes elevated blood levels of acetaldehyde.
Because the prevalence of drinking differs among countries depending on culture, the proportion of colorectal cancer cases attributable to alcohol drinking, called the population-attributable fraction (PAF), is a helpful means of estimating the burden in each country. At a country level, the recent Global PAF of alcohol consumption for colorectal cancer was estimated at 4.6 % in men and 1.7 % in women [9], and by country at 11.2 % in men and 2.7 % in women in France [10], 15.5 % and 6.9 % in the United Kingdom [11], 2.3 % in men and 0.3 % in China [12], and 32.9 % in men and 2.1 % in women in Japan [13], with these cases regarded as having been preventable by the avoidance of alcohol drinking.
The association between alcohol consumption and colorectal cancer varies by dietary factors, including folate status. Low folate consumption is suggested to increase the risk of colorectal cancer [14]. The EPIC study showed that the association between alcohol intake at baseline and colorectal cancer risk was stronger in subjects with low folate intake, with a borderline significant interaction [5]. A similar result was observed in another pooled analysis [6].
Possible Mechanism
Alcohol drinking results in acetaldehyde exposure, and the carcinogenicity of acetaldehyde associated with alcoholic beverage to humans has now been confirmed as Group 1 by the IARC Working Group [1•]. However, the specific mechanisms of the effect of alcohol intake on colorectal carcinogenesis in humans have yet to be fully defined. One notable mechanism identified to date is considered to relate to the folate pathway. Dietary folate influences DNA methylation, synthesis, and repair [14]. Folate has the potential to decrease carcinogenesis by various mechanisms in relation to DNA synthesis and methylation [14]. Alcohol may induce DNA hypomethylation [15] through its antifolate effect, and subsequently induce folate deficiency [16], under which the condition of high alcohol combined with low folate may markedly increase the risk of colorectal cancer. Acetaldehyde itself is responsible for colorectal carcinogenesis via its inhibition of the intestinal absorption of potentially anticarcinogenic nutrients, such as folate [17] and calcium [18].
Genetic Polymorphisms Relating to Alcohol Metabolism
Ethanol is generally oxidized in the liver by alcohol dehydrogenases (ADH) to acetaldehyde, which is regarded as carcinogenic in humans (Group 1), and is then further detoxified to acetate by aldehyde dehydrogenases (ALDH). Genetic variants that cause functional differences in these enzyme activities result in differences in acetaldehyde exposure [19]. East Asians, such as Japanese, have a relatively high prevalence of low or no ALDH2 activity, which is considered to affect cancer etiology among drinkers [19]. For ALDH2 polymorphism, ALDH2*1 and ALDH2*2 are the active and inactive subunits of the alleles. ALDH2-deficient phenotypes are ALDH2*2 homozygous (null ALDH2 activity) and ALDH2 heterozygous (6 % residual activity) [20]. Nevertheless, several published papers on colorectal cancer in Asian populations did not observe a consistent effect of ALDH2 polymorphism and alcohol consumption on colorectal cancer risk [21, 22].
The enzyme 5,10-methylenetetrahydrofolate reductase (MTHFR) plays a crucial role in folate metabolism. MTHFR acts as catalyzer for the conversion of 5,10-methylenetetrahydrofolate, which is required for purine and thymidine syntheses, to 5-methyltetrahydrofolate, which is the primary circulatory form of folate. Folate is crucial for methionine synthesis. A common mutation (677C→T) in MTHFR reduces its enzyme activity and induces lower levels of 5-methyltetrahydrofolate [23]. Compared with the CC genotype, the TT or CT genotype results in a substantial reduction in MTHFR activity [24]. A review on this variant and colorectal cancer risk reported that the TT genotype was associated with a moderately reduced risk in most studies [25].
In general, although the role of genetic polymorphisms associated with colorectal cancer remains inconclusive due to a limited number of studies and inconsistent results, several clues to understanding the mechanism of colorectal carcinogenesis in relation to alcohol are available, namely with regard to genetic polymorphisms such as ALDH2 and MTHFR.
Conclusions
The positive association between alcohol consumption and colorectal cancer risk is convincing. Although the site-specific mechanism of the influence of alcohol intake on colorectal carcinogenesis and the effect of gene-environment interaction requires clarification, avoidance of excess alcohol drinking will substantially contribute to reducing the risk and burden of colorectal cancer attributable to alcohol drinking.
References
Papers of particular interest, published recently, have been highlighted as: • Of importance
• Secretan B, Straif K, Baan R, Grosse Y, El Ghissassi F, Bouvard V, et al. A review of human carcinogens–Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol. 2009;10(11):1033–4. 2009/11/06. This article summarizes the most recent IARC Working Group review on carcinogenisity of alcohol.
IARC, editor. A Review of human carcinogens: Personal habits and indoor combustions. Lyon, France: WHO Press; 2012.
WCRF/AICR, editor. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: A global perspective. Washington DC: AICR; 2007.
• Fedirko V, Tramacere I, Bagnardi V, Rota M, Scotti L, Islami F, et al. Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol. 2011;22(9):1958–72. 2011/02/11. This article presents the most recent global systematic reviews and meta-analysis results on alcohol drinking and colorectal cancer risk.
Ferrari P, Jenab M, Norat T, Moskal A, Slimani N, Olsen A, et al. Lifetime and baseline alcohol intake and risk of colon and rectal cancers in the European prospective investigation into cancer and nutrition (EPIC). Int J Cancer. 2007;121(9):2065–72. Epub 2007/07/21.
Cho E, Smith-Warner SA, Ritz J, van den Brandt PA, Colditz GA, Folsom AR, et al. Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med. 2004;140(8):603–13. Epub 2004/04/21.
Mizoue T, Inoue M, Wakai K, Nagata C, Shimazu T, Tsuji I, et al. Alcohol drinking and colorectal cancer in Japanese: a pooled analysis of results from five cohort studies. Am J Epidemiol. 2008;167(12):1397–406. Epub 2008/04/19.
Takeshita T, Morimoto K, Mao X, Hashimoto T, Furuyama J. Characterization of the three genotypes of low Km aldehyde dehydrogenase in a Japanese population. Hum Genet. 1994;94(3):217–23. Epub 1994/09/01.
Boffetta P, Hashibe M, La Vecchia C, Zatonski W, Rehm J. The burden of cancer attributable to alcohol drinking. Int J Cancer. 2006;119(4):884–7. Epub 2006/03/25.
International Agency for Research on Cancer. Attributable causes of cancer in France in the year 2000. IARC Working Group Report Vol. 3. Lyon, France: 2007.
Parkin DM. 3. Cancers attributable to consumption of alcohol in the UK in 2010. Br J Cancer. 2011;105 Suppl 2:S14–8. Epub 2011/12/14.
Liang H, Wang J, Xiao H, Wang D, Wei W, Qiao Y, et al. Estimation of cancer incidence and mortality attributable to alcohol drinking in China. BMC Public Health. 2010;10:730.
Inoue M, Sawada N, Matsuda T, Iwasaki M, Sasazuki S, Shimazu T, et al. Attributable causes of cancer in Japan in 2005–systematic assessment to estimate current burden of cancer attributable to known preventable risk factors in Japan. Ann Oncol. 2012;23(5):1362–9. Epub 2011/11/04.
Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr. 2002;132(8 Suppl):2350S–5. Epub 2002/08/07.
Laird PW, Jaenisch R. DNA methylation and cancer. Hum Mol Genet. 1994;3 Spec No:1487–95. Epub 1994/01/01.
Homann N, Tillonen J, Salaspuro M. Microbially produced acetaldehyde from ethanol may increase the risk of colon cancer via folate deficiency. Int J Cancer. 2000;86(2):169–73. Epub 2000/03/30.
Sanjoaquin MA, Allen N, Couto E, Roddam AW, Key TJ. Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer. 2005;113(5):825–8. Epub 2004/10/23.
Cho E, Smith-Warner SA, Spiegelman D, Beeson WL, van den Brandt PA, Colditz GA, et al. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Nat Cancer Inst. 2004;96(13):1015–22. Epub 2004/07/09.
Druesne-Pecollo N, Tehard B, Mallet Y, Gerber M, Norat T, Hercberg S, et al. Alcohol and genetic polymorphisms: effect on risk of alcohol-related cancer. Lancet Oncol. 2009;10(2):173–80. Epub 2009/02/03.
Crabb DW, Edenberg HJ, Bosron WF, Li TK. Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. The inactive ALDH2(2) allele is dominant. J Clin Invest. 1989;83(1):314–6. Epub 1989/01/01.
Yin G, Kono S, Toyomura K, Moore MA, Nagano J, Mizoue T, et al. Alcohol dehydrogenase and aldehyde dehydrogenase polymorphisms and colorectal cancer: the Fukuoka Colorectal Cancer Study. Cancer Sci. 2007;98(8):1248–53. Epub 2007/05/23.
Matsuo K, Hamajima N, Hirai T, Kato T, Koike K, Inoue M, et al. Aldehyde dehydrogenase 2 (ALDH2) genotype affects rectal cancer susceptibility due to alcohol consumption. J Epidemiol. 2002;12(2):70–6. Epub 2002/05/30.
Ma J, Stampfer MJ, Giovannucci E, Artigas C, Hunter DJ, Fuchs C, et al. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer. Cancer Res. 1997;57(6):1098–102. Epub 1997/03/15.
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10(1):111–3. Epub 1995/05/01.
Sharp L, Little J. Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol. 2004;159(5):423–43. Epub 2004/02/24.
Conflict of Interest
The content of this manuscript has not been published or submitted for publication elsewhere. I have no conflict of interest related to this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Inoue, M. Association between Alcohol Consumption and Colorectal Cancer Risk. Curr Nutr Rep 2, 71–73 (2013). https://doi.org/10.1007/s13668-012-0033-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13668-012-0033-z